3 most recent filings and news items mentioning FBLG. Updated every 60 seconds.
LeadershipJul 9, 2026Neutral
FibroBiologics appointed former NASA astronaut Dr. Kathleen Rubins to its board of directors. Her expertise in space medicine enhances the biotech firm's scientific pipeline for fibroblast-based therapies.
View filing at SEC.gov →
OfferingJun 29, 2026Positive
FibroBiologics filed a Pre-Funded Common Stock Purchase Warrant allowing investors to buy shares at a nominal price. This security structure allows the company to raise capital without triggering immediate dilution for existing public shareholders.
View filing at SEC.gov →
OtherJun 23, 2026Positive
FibroBiologics filed a new 2026 Equity and Incentive Compensation Plan to establish rules for granting awards. The document defines key terms for stock options and cash incentives, supporting potential long-term employee retention.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.